Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease. DETECT (DEtection and Treatment of Early Cardiovascular Disease Trial).

Trial Profile

Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease. DETECT (DEtection and Treatment of Early Cardiovascular Disease Trial).

Completed
Phase of Trial: Phase I/II

Latest Information Update: 02 Dec 2017

At a glance

  • Drugs Carvedilol (Primary) ; Lisinopril
  • Indications Borderline hypertension
  • Focus Therapeutic Use
  • Acronyms DETECT
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 03 Feb 2012 Actual end date Dec 2010 added as reported by ClinicalTrials.gov.
    • 21 May 2011 Status changed from active, no longer recruiting to completed, according to 2011 ASH abstract.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top